Hospital leaders all around the country are using the financial impact of COVID-19 as the impetus to renegotiate implant contracts. These contracts should be revised for the benefit of the hospital and should consider the total cost of business in the vendor process. It may be appropriate to add penalties for excessive inventory being brought for cases, or for late deliveries that cause rush processing. Hospitals can also take this opportunity to look at databases that identify functionally equivalent implants. This is the basis to have conversations with clinicians about using on-contract implants that are functionally equivalent to their preferred off-contract vendor. It is expected that many health systems going through this process will end up working with fewer vendors, but they will build deeper working relationships with those vendors.
-#ReadySetSurgical #ImplantManagement #KPIs #DataDriven #SterileProcessing #SupplyChain #1CE #IAHCSMM #CBSPD